At a glance
ClinicalIndex Comparison RecordN/ACompleted· 114 enrolled
Drug / intervention
gentamicin +1 moredrug
Likely dose
gentamicin 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparing Addition of Gentamicin vs. Placebo in Preventing Post ERCP Cholangitis in Non-calculus Stenting
In Brief
A clinical study evaluating gentamicin and Placebo for Cholangitis. Completed, enrolled 114 participants across 1 site.
Detailed Summary
Cholangitis is the most prevalent infectious complication of ERCP. Stenting of biliary strictures and stenosis is one of important risk factors for post-ERCP cholangitis. Adding antibiotics to contrast media has proposed in some studies for prevention of cholangitis but remains controversial. In this study we compare effect of adding gentamicin versus placebo in preventing cholangitis in patients who undergone endoscopic stenting for non-calculus strictures and stenosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholangitis
CountriesIran
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2009
First PostedJun 2010
Primary CompletionDec 2010
TodayJul 2026
First PostedJun 22, 2010
Enrollment StartDec 1, 2009
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 16.0 years ago
Interventions
gentamicindrug
10mg per 10ml of contrast media
Placebodrug
Distilled water